166 results on '"Sueta, Aiko"'
Search Results
2. A progressive and refractory case of breast cancer with Cowden syndrome
3. Analysis of plasma HER2 copy number in cell-free DNA of breast cancer patients: a comparison with HER2 extracellular domain protein level in serum
4. Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers
5. Lenvatinib, an oral multi-kinases inhibitor, -associated hypertension: Potential role of vascular endothelial dysfunction
6. Droplet digital polymerase chain reaction assay for screening of ESR1 mutations in 325 breast cancer specimens
7. Prognostic Factors for Cancer Therapeutics-Related Cardiac Dysfunction in Breast Cancer Patients Treated with Current Anthracycline Regimens
8. Clinical significance of plasma cell-free DNA mutations in PIK3CA, AKT1, and ESR1 gene according to treatment lines in ER-positive breast cancer
9. Factors involved in early lenvatinib dose reduction: a retrospective analysis
10. Influence of the C5a–C5a receptor system on breast cancer progression and patient prognosis
11. Successful ethinylestradiol therapy for a metastatic breast cancer patient with heavily pre-treated with endocrine therapies
12. Immunohistochemical analysis in ethinylestradiol-treated breast cancers after prior long-term estrogen-deprivation therapy
13. Cardiac computed tomography‐derived myocardial tissue characterization after anthracycline treatment
14. WS8-3 - Incidence and clinical relevance of ESR1 mutations in estrogen receptor positive breast cancer patients
15. Clinical significance of CYLD downregulation in breast cancer
16. Prognostic Factors for Cancer Therapeutics-Related Cardiac Dysfunction in Breast Cancer Patients Treated with Current Anthracycline Regimens
17. Exosomal miRNA profiles of triple‑negative breast cancer in neoadjuvant treatment
18. Differential impact of body mass index and its change on the risk of breast cancer by molecular subtype: A case-control study in Japanese women
19. High recurrence risk and use of adjuvant trastuzumab in patients with small, HER2-positive, node-negative breast cancers
20. A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population
21. Stromal sarcoma of the breast with lung metastases showing a clinical complete response to doxorubicin plus ifosfamide treatment: Report of a case
22. Clinical significance of pretherapeutic Ki67 as a predictive parameter for response to neoadjuvant chemotherapy in breast cancer; is it equally useful across tumor subtypes?
23. Cardiac computed tomography-derived extracellular volume fraction in late anthracycline-induced cardiotoxicity
24. Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls
25. Abstract P5-11-12: Clinical value ofESR1mutations from cell free DNA in ethynil estradiol treatment for metastatic breast cancer
26. Abstract P2-11-17: Expression levels of some genes associated with tumor shrinkage by neoadjuvant endocrine therapy were paradoxically related with poor prognosis in patients with ER-positive/HER2-negative operable breast cancer
27. Additional file 1: of Clinical significance of plasma cell-free DNA mutations in PIK3CA, AKT1, and ESR1 gene according to treatment lines in ER-positive breast cancer
28. The role of exosomal microRNAs; focus on clinical applications in breast cancer
29. Therapeutic predictors of neoadjuvant endocrine therapy response in estrogen receptor-positive breast cancer with reference to optimal gene expression profiling
30. APOBEC3B gene expression as a novel predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer
31. Abstract 1583: Clinical significance ofPIK3CA,AKT1, andESR1mutation in plasma cell-free DNA from estrogen receptor-positive breast cancer patients
32. ESR1 and PIK3CA mutational status in serum and plasma from metastatic breast cancer patients: A comparative study
33. Genetic and environmental factors and serum hormones, and risk of estrogen receptor-positive breast cancer in pre- and postmenopausal Japanese women
34. Prevalence of ESR1 E380Q mutation in tumor tissue and plasma from Japanese breast cancer patients
35. Incidence and clinical relevance of ESR1 mutations in estrogen receptor positive breast cancer patients
36. Comparison of ESR1 Mutations in Tumor Tissue and Matched Plasma Samples from Metastatic Breast Cancer Patients
37. Genetic and environmental factors and serum hormones, and risk of estrogen receptor-positive breast cancer in pre- and postmenopausal Japanese women
38. Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence
39. Analysis of ESR1 and PIK3CA mutations in plasma cell-free DNA from ER-positive breast cancer patients
40. Clinical features of lenvatinib treatment in elderly patients with advanced thyroid cancer
41. Associations of single-nucleotide polymorphism (SNP) with breast cancer risk in a Japanese women
42. Clinical significance of monitoring ESR1 mutations in circulating cell-free DNA in estrogen receptor positive breast cancer patients
43. Fibroblast growth factor receptor‐1 protein expression is associated with prognosis in estrogen receptor‐positive/human epidermal growth factor receptor‐2‐negative primary breast cancer
44. Abstract A40: ESR1 gene alterations in the metastatic breast cancer with resistance to aromatase inhibitor
45. Abstract A44: Clinical significance of ESR1 mutations by cell-free DNA in recurrent/metastatic breast cancer
46. <italic>ESR1</italic> and <italic>PIK3CA</italic> mutational status in serum and plasma from metastatic breast cancer patients: A comparative study.
47. Associations Between Elastography Findings and Clinicopathological Factors in Breast Cancer
48. Prognostic role ofPIK 3 CAmutations of cell‐free DNA in early‐stage triple negative breast cancer
49. Influence of the C5a–C5a receptor system on breast cancer progression and patient prognosis
50. Abstract P6-01-20: A role of MACC1 expression and its regulation of the HGF/c-Met pathway in breast cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.